Kerrisdale Advisers’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,265
Closed -$709K 77
2025
Q3
$709K Hold
7,265
0.37% 52
2025
Q2
$506K Buy
+7,265
New +$414K 0.26% 46
2024
Q4
Sell
-2,730
Closed -$286K 87
2024
Q3
$286K Buy
+2,730
New +$319K 0.1% 88

Other funds holding ACLS

Kerrisdale Advisers's ACLS Position: Q4 2025 in Review

Kerrisdale Advisers sold out of Axcelis (ACLS) in Q4 2025, closing a stake of 7,265 shares — an estimated $709K sold.

Kerrisdale Advisers first reported a position in ACLS in Q3 2024 and held it in 3 quarters. The position peaked at $709K in Q3 2025. 370 funds tracked by Wall St. Rank hold ACLS as of Q4 2025.

  • Kerrisdale Advisers reported no remaining Axcelis position as of Q4 2025 after selling out during the quarter.
  • Kerrisdale Advisers sold 7,265 Axcelis shares in Q4 2025, an estimated $709K.
  • Kerrisdale Advisers first reported a position in Axcelis in Q3 2024 and held it in 3 quarters.
  • Kerrisdale Advisers's Axcelis position peaked at $709K in Q3 2025.
  • 370 funds tracked by Wall St. Rank held Axcelis as of Q4 2025.

Based on Kerrisdale Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.